{"title":"Cost-effectiveness of tenofovir alafenamide and entecavir in chronic hepatitis B in Saudi Arabia.","authors":"Ahmed Al-Jedai","doi":"10.4103/sjg.sjg_277_23","DOIUrl":"10.4103/sjg.sjg_277_23","url":null,"abstract":"","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":"1 1","pages":"1-3"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10852149/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42267348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Ahmed Alwassief, Said Al-Busafi, Qasim L Abbas, Khalid Al Shamusi, Sarto C Paquin, Anand V Sahai
{"title":"Endohepatology: The endoscopic armamentarium in the hand of the hepatologist.","authors":"Ahmed Alwassief, Said Al-Busafi, Qasim L Abbas, Khalid Al Shamusi, Sarto C Paquin, Anand V Sahai","doi":"10.4103/sjg.sjg_214_23","DOIUrl":"10.4103/sjg.sjg_214_23","url":null,"abstract":"<p><strong>Abstract: </strong>Recent advances in the field of hepatology include new and effective treatments for viral hepatitis. Further effort is now being directed to other disease entities, such as non-alcoholic fatty liver disease, with an increased need for assessment of liver function and histology. In fact, with the evolving nomenclature of fat-associated liver disease and the emergence of the term \"metabolic-associated fatty liver disease\" (MAFLD), new diagnostic challenges have emerged as patients with histologic absence of steatosis can still be classified under the umbrella of MAFLD. Currently, there is a growing number of endoscopic procedures that are pertinent to patients with liver disease. Indeed, interventional radiologists mostly perform interventional procedures such as percutaneous and intravascular procedures, whereas endoscopists focus on screening for and treatment of esophageal and gastric varices. EUS has proven to be of value in many areas within the realm of hepatology, including liver biopsy, assessment of liver fibrosis, measurement of portal pressure, managing variceal bleeding, and EUS-guided paracentesis. In this review article, we will address the endoscopic applications that are used to manage patients with chronic liver disease.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":" ","pages":"4-13"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10852142/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138177630","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"An algorithm-based active cleansing protocol can reduce the bowel preparation time for screening colonoscopy: A propensity score matching study.","authors":"Fumiaki Ishibashi, Sho Suzuki, Ryu Tanaka, Konomi Kobayashi, Tomohiro Kawakami, Mizuki Nagai, Kentaro Mochida, Tetsuo Morishita","doi":"10.4103/sjg.sjg_176_23","DOIUrl":"10.4103/sjg.sjg_176_23","url":null,"abstract":"<p><strong>Background: </strong>Methods that minimize the time for on-site bowel preparation before colonoscopy are needed. We prospectively validated that a novel algorithm-based active cleansing (ABAC) protocol could reduce the time for preparation compared with the conventional method.</p><p><strong>Methods: </strong>This was an open-label, multicenter, prospective comparative study from April to October 2021. The study compared the bowel preparation time for colonoscopy between patients instructed with the ABAC protocol and control groups. Patients in the ABAC protocol group as well as the control group were administered 2000 mL of polyethylene glycol (PEG) within 2 hours. After the first two hours, patients in the protocol group voluntarily took 300 ml of the solution without the instruction of nursing staff depending on the number of defecations in the first 2 hours. The intervention and control groups were adjusted for background characteristics by propensity score matching (PSM).</p><p><strong>Results: </strong>After adjustment by PSM, 174 patients in each of the two groups were included in the final analysis. In the intention-to-treat analysis, the preparation time was significantly shorter in the intervention group than that in the control group (126.3 ± 32.7 min vs. 144.9 ± 39.9 min, P = 0.018). The proportion of additional PEG intake was significantly higher in the intervention group (16 [9.2%] vs. 6 [3.4%], P = 0.047). The number of defecations was also higher in the intervention group than in the control group (7.8 ± 2.5 vs. 6.3 ± 2.2, P = 0.001).</p><p><strong>Conclusions: </strong>Simple active instruction protocol is effective to reduce on-site bowel preparation time and nursing staff labor for colonoscopy.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":" ","pages":"30-36"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10852146/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9835198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Emad S Aljahdli, Ftoon Badroun, Hanan H Mushaeb, Raghad Aljohani, Sara Albisher, Leena Basalaim, Salma Baeisa
{"title":"Effects of irritable bowel syndrome on the health-related quality of life among the Saudi population.","authors":"Emad S Aljahdli, Ftoon Badroun, Hanan H Mushaeb, Raghad Aljohani, Sara Albisher, Leena Basalaim, Salma Baeisa","doi":"10.4103/sjg.sjg_107_23","DOIUrl":"10.4103/sjg.sjg_107_23","url":null,"abstract":"<p><strong>Background: </strong>Irritable bowel syndrome (IBS) is a digestive system disorder. Patients with IBS have a significantly lower quality of life (QoL). In this study, we aimed to assess how IBS affects the Saudi Arabian population's health-related (HR)-QoL.</p><p><strong>Methods: </strong>A cross-sectional Web-based survey was conducted with a representative sample (n = 1346) of patients who met the Rome IV criteria for IBS from all regions of the country between February and May 2021. The questionnaire surveyed participants' socio-demographic data (nationality, sex, age, region, marital status, level of education, and occupation) and included 24 questions on IBS divided into four categories: (1) diagnosis; (2) symptoms; (3) impact on patients' lives; and (4) management methods. The HR-QoL score was calculated using a five-point Likert scale, with higher scores indicating worse QoL.</p><p><strong>Results: </strong>Most patients (83.3%) were diagnosed by a physician, and 66.7% had a family member or a friend with IBS. Mixed IBS was the most common type of IBS (26.4%). Factors associated with poor QoL and significantly associated with IBS included female sex, initial diagnosis by a general physician, intermittent symptoms, and being asymptomatic for weeks to months.</p><p><strong>Conclusions: </strong>Greater attention to the QoL of patients with IBS is required to help them deal with IBS and create supportive environments to reduce its psychological effects.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":" ","pages":"37-44"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10852141/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10060063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Christo Mathew, Ankur Patel, George Cholankeril, Avegail Flores, Ruben Hernaez
{"title":"Using noninvasive clinical parameters to predict mortality and morbidity after cardiac interventions in patients with cirrhosis: A systematic review.","authors":"Christo Mathew, Ankur Patel, George Cholankeril, Avegail Flores, Ruben Hernaez","doi":"10.4103/sjg.sjg_263_23","DOIUrl":"10.4103/sjg.sjg_263_23","url":null,"abstract":"<p><strong>Background: </strong>Cardiovascular disease commonly affects advanced liver disease patients. They undergo cardiac interventions to improve cardiac outcomes. Cirrhosis increases complication risk, including bleeding, renal and respiratory failure, and further decompensation, including death, posing a clinical dilemma to proceduralists. Predicting outcomes is crucial in managing patients with cirrhosis. Our aim was to systematically review clinical parameters to assess the mortality and complication risk in patients with cirrhosis undergoing cardiac interventions.</p><p><strong>Methods: </strong>We searched cirrhosis and cardiovascular intervention terminology in PubMed and Excerpta Medica Database (EMBASE) from inception to January 8, 2023. We included studies reporting clinical scores (e.g. Model for End-stage Liver Disease (MELD), Child-Pugh-Turcotte (CPT), cardiovascular interventions, mortality, and morbidity outcomes). We independently abstracted data from eligible studies and performed qualitative summaries.</p><p><strong>Results: </strong>Eight studies met the inclusion criteria. Procedures included tricuspid valve surgery, catheterization-related procedures, aortic valve replacement (AVR), pericardiectomy, and left ventricular assist device (LVAD) placement. MELD primarily predicted mortality (n = 4), followed by CPT (n = 2). Mortality is significantly increased for MELD > 15 after tricuspid valve surgery. Albumin, creatinine, and MELD were significantly associated with increased mortality after transcatheter AVR (TAVR), although specific values lacked stratification. CPT was significantly associated with increased mortality after cardiac catheterization or pericardiectomy. In LVAD placement, increasing MELD increased the unadjusted odds for perioperative mortality.</p><p><strong>Conclusions: </strong>Our systematic review showed that clinical parameters predict mortality and morbidity risk in patients with cirrhosis undergoing cardiac procedures.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":" ","pages":"14-22"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10852145/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138177631","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yanrong Yao, Jingli Liu, Hongmei Xue, Xiaoyan Wang, Weijie Yao, Na Liu, Zuozheng Wang, Guangli Mi
{"title":"Construction of an enteral nutrition evaluation system for critically ill patients based on the Delphi method.","authors":"Yanrong Yao, Jingli Liu, Hongmei Xue, Xiaoyan Wang, Weijie Yao, Na Liu, Zuozheng Wang, Guangli Mi","doi":"10.4103/sjg.sjg_205_23","DOIUrl":"10.4103/sjg.sjg_205_23","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to construct an enteral nutrition evaluation system for critically ill patients using the Delphi method to direct the formulation of enteral nutrition support strategies and reduce interruption to enteral feeding.</p><p><strong>Methods: </strong>We used domestic and foreign databases to obtain and analyze the literature and form \"The Whole-Proceeding Enteral Nutrition Evaluation System for Critically Ill Patients.\" The Delphi method was used to conduct two rounds of expert opinion consultation, combined with the suggestions from the research group to finalize the nutrition evaluation content of the system.</p><p><strong>Results: </strong>After two rounds of expert consultation, a nutrition evaluation system was formed around three dimensions: before the start, during, and after the end of nutritional support. The effective recovery rates of the two rounds of expert consultation were 90.0% (18/20) and 100.0% (18/18), respectively. Authority coefficients were 0.865 and 0.908, while Kendall coordination coefficients were 0.108 ( P < 0.05) and 0.115 ( P < 0.001), respectively. Finally, the full enteral nutrition evaluation system for critically ill patients was constructed based on the Delphi method, including three primary items and seven secondary and 28 tertiary indicators.</p><p><strong>Conclusion: </strong>The established \"Whole-Proceeding Enteral Nutrition Evaluation System for Critically Ill Patients\" has high consistency from expert opinions and reliability, which can provide a practical evaluation tool for the process of enteral nutrition for severe patients.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":" ","pages":"63-70"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10852151/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10291369","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Is IBD disk a reliable tool in Saudi Arabia?","authors":"Zahra A Al Saeed, Turki AlAmeel","doi":"10.4103/sjg.sjg_358_23","DOIUrl":"10.4103/sjg.sjg_358_23","url":null,"abstract":"","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":" ","pages":"71"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10852150/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"89720134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Yaser Meeralam, Adnan B Al-Zanbagi, Mohammed K Shariff
{"title":"Author response to \"Is IBD disk a reliable tool in Saudi Arabia?\"","authors":"Yaser Meeralam, Adnan B Al-Zanbagi, Mohammed K Shariff","doi":"10.4103/sjg.sjg_414_23","DOIUrl":"10.4103/sjg.sjg_414_23","url":null,"abstract":"","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":" ","pages":"72"},"PeriodicalIF":1.9,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10852147/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139058952","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Nahla A Azzam, Abdulelah Almutairdi, Hajer Y Almudaiheem, Turki AlAmeel, Shakir A Bakkari, Othman R Alharbi, Khalidah A Alenzi, Maha A AlMolaiki, Bedor A Al-Omari, Rayan G Albarakati, Ahmed H Al-Jedai, Omar I Saadah, Majid A Almadi, Badr Al-Bawardy, Mahmoud H Mosli
{"title":"Saudi consensus guidance for the management of inflammatory bowel disease during pregnancy.","authors":"Nahla A Azzam, Abdulelah Almutairdi, Hajer Y Almudaiheem, Turki AlAmeel, Shakir A Bakkari, Othman R Alharbi, Khalidah A Alenzi, Maha A AlMolaiki, Bedor A Al-Omari, Rayan G Albarakati, Ahmed H Al-Jedai, Omar I Saadah, Majid A Almadi, Badr Al-Bawardy, Mahmoud H Mosli","doi":"10.4103/sjg.sjg_318_23","DOIUrl":"10.4103/sjg.sjg_318_23","url":null,"abstract":"<p><strong>Abstract: </strong>The management of inflammatory bowel disease (IBD) in pregnant women is challenging and must be addressed on a patient-by-patient basis. Optimal patient management requires a multidisciplinary team and clear evidence-based recommendations that cater to this subset of patients. In this article, we provide concise guidelines and clinical care pathway for the management of IBD in pregnant women. Our recommendations were developed by a multidisciplinary working group that includes experts from the Saudi Ministry of Health in collaboration with the Saudi Gastroenterology Association and the Saudi Society of Clinical Pharmacology. All recommendations are based on up-to-date information following an extensive literature review. A total of 23 evidence-based expert opinion recommendations for the management of IBD in pregnant women are herein provided.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":" ","pages":""},"PeriodicalIF":1.9,"publicationDate":"2023-12-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11379253/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138806006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Vonoprazan-amoxicillin dual therapy for <i>Helicobacter pylori</i> eradication: A systematic review and meta-analysis of randomized controlled trials.","authors":"Ben-Gang Zhou, Yu-Zhou Mei, Xin Jiang, Ai-Jing Zheng, Yan-Bing Ding","doi":"10.4103/sjg.sjg_153_23","DOIUrl":"10.4103/sjg.sjg_153_23","url":null,"abstract":"<p><strong>Background: </strong>Vonoprazan-amoxicillin (VA) dual therapy has recently been proposed to eradicate Helicobacter pylori (H. pylori) with controversial results. We, therefore, conducted a meta-analysis to assess the effect of this therapy for H. pylori eradication.</p><p><strong>Methods: </strong>We searched PubMed, Embase, Cochrane Library, and Web of Science database from inception until November 2022, collecting randomized controlled trials (RCTs) comparing VA dual therapy with other regimens for H. pylori eradication. Pooled relative risks (RRs) were calculated using random effects model.</p><p><strong>Results: </strong>Five RCTs were ultimately included. Compared with the vonoprazan-amoxicillin-clarithromycin (VAC) triple therapy, the eradication rate of VA dual therapy was lower in intention-to-treat (ITT) analysis (n = 3 RCTs, RR = 0.94, 95% CI: 0.88-0.99, P = 0.03), but there was no significant difference between them in the per-protocol (PP) analysis (RR = 0.96, 95% CI: 0.91-1.01, P = 0.11). For clarithromycin-resistant H. pylori strains, the eradication rate of VA dual therapy was significantly higher than that of the VAC triple therapy (n = 2 RCTs, RR = 1.20, 95% CI: 1.03-1.39, P = 0.02). Compared with the PPI-based triple therapy (PAC), VA dual therapy had a superior eradication rate (n = 2 RCTs, ITT analysis: RR = 1.13, 95% CI: 1.04-1.23, P = 0.003; PP analysis: pooled RR = 1.14, 95% CI: 1.06-1.22, P = 0.0004). Compared with VAC or PAC triple therapy, VA dual therapy has a similar incidence of total adverse events and compliance.</p><p><strong>Conclusions: </strong>VA dual therapy had a similar effect compared to VAC triple therapy and was superior to PAC triple therapy. Future RCTs are needed to ascertain the optimal dosage and duration of vonoprazan and amoxicillin, and the effect of VA dual therapy compared with the mainstream regimens recommended by current guidelines.</p>","PeriodicalId":48881,"journal":{"name":"Saudi Journal of Gastroenterology","volume":"29 6","pages":"347-357"},"PeriodicalIF":2.7,"publicationDate":"2023-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10754379/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138292083","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}